Reports from Georgia State University Describe Recent Advances in Disease Progression (Quantitative Proteomics Reveals Serum Proteome Alterations During Metastatic Disease Progression In Breast Cancer Patients).

A recent study conducted at Georgia State University focused on identifying proteomic alterations in breast cancer patients during metastatic disease progression. The researchers analyzed serum samples from 51 breast cancer patients, comparing those who developed metastases with those who did not. They identified specific proteins that were altered in patients with metastatic disease, highlighting the potential for these proteins to serve as non-invasive markers for monitoring breast cancer progression. This study lays the groundwork for future investigations into the role of these proteins in breast cancer progression. [Extracted from the article]